Overall, these data show that, compared to treatment naive ATB patients, the frequencies of caspase-3+IFN-γ+CD4+ T cells were significantly reduced after successful completion of the 6-month standard regimen of anti-TB treatment (Figures 6 and 7). This evidence concerns the gene CD4 and tuberculosis.